InvestorsHub Logo

JPsooner

09/29/14 9:46 AM

#100200 RE: daBoze #100198

I think that you should email the company and ask them this question.

I am encourage to see a couple of insider buys last month:

http://openinsider.com/search?q=nnvc

Snowy_Owl

09/29/14 10:06 AM

#100202 RE: daBoze #100198

"dose ranging studies were done at Kard Scientific, with results indicating no or low toxicity."

Ebola has justified the streamlining of experimental drugs. What if the spread of Ebola exceeds projections?

Pure speculation on my part but could Ebola present opportunities that NNVC may feel obligated to explore?